Cargando…
Perceptions of COPD patients of the proposed withdrawal of inhaled corticosteroids prescribed outside guidelines: A qualitative study
Global Initiative for Chronic Obstructive Lung Disease guidelines support the prescription of fixed combination inhaled corticosteroids (ICS) and long-acting β-agonists in symptomatic COPD patients with frequent or severe exacerbations, with the aim of preventing them. ICS are frequently also prescr...
Autores principales: | Gilworth, Gill, Harries, Timothy, Corrigan, Chris, Thomas, Mike, White, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566471/ https://www.ncbi.nlm.nih.gov/pubmed/31195812 http://dx.doi.org/10.1177/1479973119855880 |
Ejemplares similares
-
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
por: Harries, Timothy H, et al.
Publicado: (2019) -
Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial
por: Harries, Timothy H, et al.
Publicado: (2022) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019) -
Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016) -
COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
por: Savran, Osman, et al.
Publicado: (2019)